U.K. Pharmaceuticals & Biotech Most Popular Stocks

AstraZeneca

Market Cap: UK£236.8b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

GSK

Market Cap: UK£88.8b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Haleon

Market Cap: UK£36.5b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Hikma Pharmaceuticals

Market Cap: UK£3.6b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Genus

Market Cap: UK£2.1b

Produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.

HUTCHMED (China)

Market Cap: UK£1.9b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Oxford Nanopore Technologies

Market Cap: UK£1.3b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA.

Oxford Biomedica

Market Cap: UK£957.0m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Allergy Therapeutics

Market Cap: UK£638.7m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally.

PureTech Health

Market Cap: UK£306.9m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Avacta Group

Market Cap: UK£253.7m

Engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally.

Animalcare Group

Market Cap: UK£191.9m

Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

Scancell Holdings

Market Cap: UK£137.5m

A clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom.

Diaceutics

Market Cap: UK£127.4m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

Shield Therapeutics

Market Cap: UK£103.1m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

Bioventix

Market Cap: UK£86.2m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

4basebio

Market Cap: UK£85.9m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally.

ECO Animal Health Group

Market Cap: UK£69.8m

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally.

hVIVO

Market Cap: UK£64.0m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Hemogenyx Pharmaceuticals

Market Cap: UK£63.7m

A clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer.

Faron Pharmaceuticals Oy

Market Cap: UK£57.9m

Operates as a clinical stage drug discovery and development company.

ImmuPharma

Market Cap: UK£42.7m

A biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom.

Poolbeg Pharma

Market Cap: UK£33.1m

A clinical-stage biopharmaceutical company, focused on acquiring, developing, and commercialising of medicines for unmet medical needs in the United Kingdom.

Arecor Therapeutics

Market Cap: UK£27.4m

A clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom.

Aptamer Group

Market Cap: UK£26.3m

Provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.

Palatin Technologies

Market Cap: US$35.4m

A biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States.

Sareum Holdings

Market Cap: UK£21.4m

A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.

Fusion Antibodies

Market Cap: UK£17.7m

A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.

Solvonis Therapeutics

Market Cap: UK£16.3m

A clinical-stage biopharmaceutical company, develops novel medicines for addiction and mental health disorders.

SkinBioTherapeutics

Market Cap: UK£13.5m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

ProBiotix Health

Market Cap: UK£12.7m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

Oxford BioDynamics

Market Cap: UK£12.2m

Operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom.

genedrive

Market Cap: UK£10.8m

Engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.

Verici Dx

Market Cap: UK£9.5m

Together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States.

CRISM Therapeutics

Market Cap: UK£8.9m

Develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs.

Genflow Biosciences

Market Cap: UK£8.9m

Engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium.